Mabion SA (0QGW) Share Price & Analysis
0QGW Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- PLN 127.68M
- Enterprise Value
- PLN 147.21M
- Total Cash (Recent Filing)
- PLN 5.79M
- Total Debt (Recent Filing)
- PLN 32.44M
- Price to Earnings (P/E)
- ―
- Beta
- N/A
- Next Earnings
- Nov 17, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Operational Efficiency
Maintaining a positive EBITDA margin indicates operational efficiency, allowing the company to cover its operating expenses and potentially improve profitability over time.
Strong Balance Sheet
A strong equity position with low financial leverage suggests financial stability, enabling the company to withstand economic fluctuations and invest in growth opportunities.
Cash Flow Improvement
Significant improvement in free cash flow indicates enhanced cash generation capabilities, providing more flexibility for future investments and operations.
Bears Say
Declining Gross Profit Margin
A declining gross profit margin indicates rising costs or pricing pressures, which could erode profitability and limit resources available for growth initiatives.
Negative Profitability
Negative profitability highlights issues in cost management or pricing strategy, posing risks to the company's financial health and ability to reinvest in its business.
Declining Revenue
A substantial drop in revenue suggests challenges in market demand or competitive positioning, which could impact the company's ability to sustain growth and profitability.
0QGW FAQ
What is Mabion SA’s market cap?
When is Mabion SA’s upcoming earnings report date?
How were Mabion SA’s earnings last quarter?
Is Mabion SA overvalued?
Does Mabion SA pay dividends?
What is Mabion SA’s EPS estimate?
How many shares outstanding does Mabion SA have?
What happened to Mabion SA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Mabion SA?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Mabion SA
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Krzysztof Kaczmarczyk
- Employees
- 202
- Website
- www.mabion.eu
- Address
- Medical Biotechnology Scientific and Industrial Complex, Konstantynów Lódzki, LDZ, 95-050, PL
